Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density.

Autor: Stout NK; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts., Miglioretti DL; Department of Public Health Sciences, University of California Davis School of Medicine, Davis., Su YR; Kaiser Permanente Washington Health Research Institute, Seattle., Lee CI; Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle., Abraham L; Kaiser Permanente Washington Health Research Institute, Seattle., Alagoz O; Department of Industrial and Systems Engineering and Department of Population Health Sciences and Carbone Cancer Center, University of Wisconsin-Madison, Madison., de Koning HJ; Department of Public Health, Erasmus University Medical Center Rotterdam, the Netherlands., Hampton JM; Department of Industrial and Systems Engineering and Department of Population Health Sciences and Carbone Cancer Center, University of Wisconsin-Madison, Madison., Henderson L; Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill., Lowry KP; Fred Hutchinson Cancer Center University of Washington School of Medicine, Seattle., Mandelblatt JS; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Department of Oncology and Georgetown Lombardi Institute for Cancer and Aging REsearch (I-CARE), Georgetown University, Washington, DC., Onega T; Department of Population Health Sciences, and the Huntsman Cancer Institute, University of Utah, Salt Lake City., Schechter CB; Department of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, New York., Sprague BL; Department of Surgery, University of Vermont Cancer Center, Burlington, Vermont.; University of Vermont Larner College of Medicine, Burlington.; Department of Radiology, University of Vermont Cancer Center, Burlington, Vermont., Stein S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts., Trentham-Dietz A; Department of Population Health Sciences and Carbone Cancer Center, University of Wisconsin-Madison, Madison., van Ravesteyn NT; Department of Public Health, Erasmus University Medical Center Rotterdam, the Netherlands., Wernli KJ; Kaiser Permanente Washington Health Research Institute, Seattle., Kerlikowske K; Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco., Tosteson ANA; The Dartmouth Institute for Health Policy and Clinical Practice, Departments of Medicine and of Community and Family Medicine, and Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.

Publikováno v: JAMA internal medicine [JAMA Intern Med] 2024 Oct 01; Vol. 184 (10), pp. 1222-1231.

Impact of different age ranges on the benefits and harms of the breast cancer screening programme by the EU-TOPIA tool.

Autor: Pinto-Carbó M; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., Vanaclocha-Espí M; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., Martín-Pozuelo J; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., Romeo-Cervera P; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., Hernández-García M; Environmental Health Service, Utiel Public Health Centre, Ministry of Universal and Public Health, Utiel, Valencia Region, Spain., Ibáñez J; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain.; Healthcare Integration Service, Directorate General for Health Care, Regional Ministry of Health, Valencia, Spain., Castán-Cameo S; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain.; Screening Programs Service, General Directorate of Public Health, Regional Ministry of Health, Valencia, Spain., Salas D; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., van Ravesteyn NT; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands., de Koning H; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Zurriaga Ó; Department of Preventive Medicine and Public Health, Food Sciences, Toxicology and Legal Medicine, University of Valencia, Valencia, Spain.; Joint Research Unit on Rare Diseases, FISABIO-University of Valencia (FISABIO-UVEG), Valencia, Spain., Molina-Barceló A; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain.

Publikováno v: European journal of public health [Eur J Public Health] 2024 Aug 01; Vol. 34 (4), pp. 806-811.

Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.

Autor: Trentham-Dietz A; Department of Population Health Sciences and Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison., Chapman CH; Department of Radiation Oncology and Center for Innovations in Quality, Safety, and Effectiveness, Baylor College of Medicine, Houston, Texas., Jayasekera J; Health Equity and Decision Sciences (HEADS) Research Laboratory, Division of Intramural Research at the National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, Maryland., Lowry KP; University of Washington School of Medicine, Seattle., Heckman-Stoddard BM; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Hampton JM; Department of Population Health Sciences and Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison., Caswell-Jin JL; Department of Medicine, Stanford University School of Medicine, Stanford, California., Gangnon RE; Department of Population Health Sciences and Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison.; Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin-Madison., Lu Y; Stanford University, Stanford, California., Huang H; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Stein S; Harvard Pilgrim Health Care Institute, Boston, Massachusetts., Sun L; Stanford University, Stanford, California., Gil Quessep EJ; Erasmus MC-University Medical Center, Rotterdam, the Netherlands., Yang Y; University of Texas MD Anderson Cancer Center, Houston., Lu Y; Department of Industrial and Systems Engineering and Carbone Cancer Center, University of Wisconsin-Madison., Song J; University of Texas MD Anderson Cancer Center, Houston., Muñoz DF; Stanford University, Stanford, California., Li Y; University of Texas MD Anderson Cancer Center, Houston., Kurian AW; Departments of Medicine and Epidemiology and Population Health, Stanford University, Stanford, California., Kerlikowske K; Departments of Medicine and Epidemiology and Biostatistics, University of California San Francisco., O'Meara ES; Kaiser Permanente Washington Health Research Institute, Seattle, Washington., Sprague BL; Department of Surgery, University of Vermont, Burlington., Tosteson ANA; Dartmouth Institute for Health Policy and Clinical Practice and Departments of Medicine and Community and Family Medicine, Dartmouth Geisel School of Medicine, Hanover, New Hampshire., Feuer EJ; Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Berry D; University of Texas MD Anderson Cancer Center, Houston., Plevritis SK; Departments of Biomedical Data Science and Radiology, Stanford University, Stanford, California., Huang X; University of Texas MD Anderson Cancer Center, Houston., de Koning HJ; Erasmus MC-University Medical Center, Rotterdam, the Netherlands., van Ravesteyn NT; Erasmus MC-University Medical Center, Rotterdam, the Netherlands., Lee SJ; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Alagoz O; Department of Industrial and Systems Engineering and Carbone Cancer Center, University of Wisconsin-Madison., Schechter CB; Albert Einstein College of Medicine, Bronx, New York., Stout NK; Harvard Pilgrim Health Care Institute, Boston, Massachusetts.; Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Miglioretti DL; Kaiser Permanente Washington Health Research Institute, Seattle, Washington.; Department of Public Health Sciences, University of California Davis., Mandelblatt JS; Departments of Oncology and Medicine, Georgetown University Medical Center, and Georgetown Lombardi Comprehensive Institute for Cancer and Aging Research at Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC.

Publikováno v: JAMA [JAMA] 2024 Jun 11; Vol. 331 (22), pp. 1947-1960.

Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy.

Autor: Zielonke N; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Senore C; Epidemiology and screening Unit - CPO, University Hospital Città della Salute e della Scienza, Turin, Italy., Ponti A; Epidemiology and screening Unit - CPO, University Hospital Città della Salute e della Scienza, Turin, Italy., Csanadi M; Syreon Research Institute, Budapest, Hungary., de Koning HJ; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Heijnsdijk EAM; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., van Ravesteyn NT; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Publikováno v: Journal of medical screening [J Med Screen] 2023 Sep; Vol. 30 (3), pp. 134-141. Date of Electronic Publication: 2023 Feb 10.

Health-related Quality of Life using the EQ-5D-5L: normative utility scores in a Dutch female population.

Autor: Clarijs ME; Department of Oncologic and Gastro-Intestinal Surgery, Academic Breast Cancer Center, Erasmus University Medical Center Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. m.clarijs@erasmusmc.nl., Kregting LM; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., van Ravesteyn NT; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Koppert LB; Department of Oncologic and Gastro-Intestinal Surgery, Academic Breast Cancer Center, Erasmus University Medical Center Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Korfage IJ; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Publikováno v: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 Feb; Vol. 32 (2), pp. 373-381. Date of Electronic Publication: 2022 Oct 20.